The dynamics of the immunological indices during the treatment of recurrent erysipelas with the new immunostimulant bemitil

Ratnikova, L.I.

Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 9: 56-58

1991


ISSN/ISBN: 0372-9311
PMID: 1759524
Document Number: 376112
Bemitil, administered orally in a dose of 0.25-0.5 g a day for 5-7 days at the acute period of the relapse of erysipelas as an immunostimulant, enhanced the effectiveness of the basic therapy including antibiotics, anti-inflammatory and antiallergic drugs, vitamins, plasma-substituting fluids and saline solutions, as well as ultraviolet irradiation of the focus of lesion. Bemitil therapy was associated with an increase in the number of T-lymphocytes, normalization of the balance between the peripheral lymphocyte preparations, an increase of blood serum levels of IgA and IgM.

Document emailed within 1 workday
Secure & encrypted payments